Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND
NCT ID: NCT07282470
Last Updated: 2026-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
210 participants
OBSERVATIONAL
2024-09-25
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liquid Biopsy in High-grade Gliomas and Meningiomas
NCT05630664
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200
Predictive Factors for Survival in Aggressive Meningiomas
NCT05793034
Plasma Extracellular Vesicles in Meningioma Patients
NCT06104930
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective Cohort
150 patients operated for non-recurrent meningioma between 2008 and 2016.
No interventions assigned to this group
Prospective Cohort
60 patients diagnosed with meningioma recruited prospectively.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First diagnosis of uni-focal meningioma of the convexity.
* Macroscopical total resection (Simpson 1-3).
(Retrospective only):
* Surgery performed between 2007 and 2016;
* availability of FFPE sample and medical records.
Exclusion Criteria
* Diffuse Meningeal Meningiomatosis.
* Patients who underwent experimental treatment in neo-adjuvant setting.
(Prospective only):
* Previous surgical/medical treatment for another meningioma;
* positive oncological history (e.g., breast cancer).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
Università degli Studi del Piemonte Orientale Amedeo Avogadro
OTHER
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIND
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.